Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2009
11/03/2009CA2385477C Pca3 messenger rna species in benign and malignant prostate tissues
11/03/2009CA2205379C Yeast-based delivery vehicles
11/03/2009CA2191064C Pantropic neurotrophic factors
11/03/2009CA2188293C Herpesviruses transformed to express gd in vitro
11/03/2009CA2187626C Aav-mediated delivery of dna to cells of the nervous system
11/03/2009CA2181548C Zinc finger protein derivatives and methods therefor
11/03/2009CA2118243C Methods and compositions for monitoring cellular processing of .beta.-amyloid precursor protein
10/2009
10/29/2009WO2009131909A2 Recombinant deamidated gliadin antigen
10/29/2009WO2009131548A1 Multimeric forms of antimicrobial peptides
10/29/2009WO2009131395A2 Angiogenic peptide
10/29/2009WO2009131191A1 Metastin derivative and use thereof
10/29/2009WO2009130709A2 A non-recombinant membrane antigen, a diagnostic kit thereof and process for detection of visceral leishmaniasis and pkdl
10/29/2009WO2009130697A1 Polynucleotides and polypeptides encoded thereby and use thereof in increasing binding affinity of dna binding proteins
10/29/2009WO2009130612A2 Prion epitopes and methods of use thereof
10/29/2009WO2009130588A2 Immunogen platform
10/29/2009WO2009130459A2 Epitopes of il-17a and il-17f and antibodies specific thereto
10/29/2009WO2009130261A1 Vaccine compositions for the treatment of dengue fever and uses thereof
10/29/2009WO2009130208A1 Liver-specific nucleic acid regulatory elements and methods and use thereof
10/29/2009WO2009130198A2 Hyperglycosylated human coagulation factor ix
10/29/2009WO2009130031A1 Artificial protein scaffolds
10/29/2009WO2009129857A1 Hexapeptides and compositions thereof
10/29/2009WO2009129743A1 Gif1 promoter and uses thereof
10/29/2009WO2009129616A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
10/29/2009WO2009106596A3 Plants with increased yield
10/29/2009WO2009105786A3 Treatment for oral disease
10/29/2009WO2009099561A3 Urinary ca125 peptides as biomarkers of ovarian cancer
10/29/2009WO2009085025A3 System and method for sparql-query processing using parametrized-sparql-query in dbms-based systems
10/29/2009WO2008101850A8 Method of producing methionine in corynebacteria by over-expressing enzymes of the pentose phosphate pathway
10/29/2009US20090271893 Nucleic Acid Sequences and Methods of Use for the Production of Plants with Modified Polyunsaturated Fatty Acids
10/29/2009US20090271892 Lysophosphatidic acid acyltransferase genes and uses thereof
10/29/2009US20090271163 Crystal structure of human factor VIII and uses thereof
10/29/2009US20090270602 Peptide nucleic acids with donor and acceptor moieties for detecting or identifying the presence, absence or quantity of a target sequence of a target molecule such as via fluorescence resonance energy transfer
10/29/2009US20090270597 Fibronectin type III (Fn3) for use as diagnostic and treatment tools in gene therapy; identifying the amino acid sequence of a polypeptide molecule capable of binding to a specific binding partner (SBP) so as to form a polypeptide:SSP complex
10/29/2009US20090270595 Il-1 related polypeptides
10/29/2009US20090270594 Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies
10/29/2009US20090270593 Nucleic acid binding substance containing catalytic nucleation nanoparticles
10/29/2009US20090270592 Purified TNFR preparations
10/29/2009US20090270591 Novel surface antigen
10/29/2009US20090270488 Process for the Selection of HIV-1 Subtype C Isolates, Selected HIV-1 Subtype Isolates, Their Genes and Modifications and Derivatives Thereof
10/29/2009US20090270483 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells
10/29/2009US20090270333 Methods of using motilin homologs
10/29/2009US20090270329 Methods of administering porcine b-domainless fviii
10/29/2009US20090270327 Lepidopteran-Active Bacillus Thuringiensis Delta-Endotoxin Compositions and Methods of Use
10/29/2009US20090270325 Growth factor
10/29/2009US20090270324 Complement depletion using recombinant human c-3 derivatives
10/29/2009US20090270322 G protein coupled receptor antagonists and methods of activating and inhibiting g protein coupled receptors using the same
10/29/2009US20090270318 High-affinity antagonists of elr-cxc chemokines
10/29/2009US20090270316 Her-2 binding antagonists
10/29/2009US20090270314 Polypeptide having anti-angiogenic activity
10/29/2009US20090270312 Hiv-i gp41 fusion peptides for immunomodulaltion
10/29/2009US20090269850 containing a reduced amount of receptor-binding protein compared with the wild type; modified HVJ containing a reduced amount of HN protein
10/29/2009US20090269848 Technique for culture of mesenchymal stem cell utilizing laminin-5
10/29/2009US20090269847 Self-assembling peptide amphiphiles and related methods for growth factor delivery
10/29/2009US20090269844 Nucleic acids encoding a receptor for il-17 homologous polypeptides
10/29/2009US20090269842 Transmembrane delivery peptide and bio-material comprising the same
10/29/2009US20090269811 Il-1 related polypeptides
10/29/2009US20090269805 Novel Lipolytic Enzyme ELIP
10/29/2009US20090269804 Methods for refolding proteins containing free cysteine residues
10/29/2009US20090269795 Mutant alpha4betadelta GABAA receptor and methods of treating anxiety or irritability
10/29/2009US20090269786 RHO1-Gamma Amino Butyric Acid C Receptor-Specific Antibodies
10/29/2009US20090269783 B7-H2 molecules, novel members of the B7 family and uses thereof
10/29/2009US20090269762 for detecting the presence of the transgene/genomic insertion region; for transgenic glyphosate tolerance; genetic engineering
10/29/2009US20090269740 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells
10/29/2009US20090269739 Kit for detection of telomerase reverse transcriptase nucleic acids
10/29/2009US20090269437 Glycerol channel gene and use thereof
10/29/2009US20090269370 Vaccines comprising multimeric hsp60 peptide carriers
10/29/2009US20090269368 Pseudomonas exotoxin a-like chimeric immunogens
10/29/2009US20090269367 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
10/29/2009US20090269363 Method for screening peptides for use in immunotherapy
10/29/2009US20090269361 Constructs for delivery of therapeutic agents to neuronal cells
10/29/2009US20090269358 Proteins with Improved Solubility and Methods for Producing and Using Same
10/29/2009US20090269350 drug screening; used to identify compounds that act as agonists and antagonists and modulate the expression of the novel PGP synthase
10/29/2009US20090269349 Antigenic polypeptides
10/29/2009US20090269348 Pancreatic Cancer Genes
10/29/2009US20090269347 Pancreatic Cancer Genes
10/29/2009US20090269346 Compositions Comprising Receptor-Associated Protein (RAP) Variants Specific for LRP2 and Uses Thereof
10/29/2009US20090269342 Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
10/29/2009US20090269341 Lytic domain fusion constructs and methods of making and using same
10/29/2009US20090269338 Humanized anti-factor d antibodies and uses thereof
10/29/2009US20090269333 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
10/29/2009US20090269332 Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor
10/29/2009US20090269320 Variants of pigment epithelium derived factor and uses thereof
10/29/2009US20090269306 N-terminal modified interferon-alpha
10/29/2009US20090269298 Agent for the prevention and treatment of sexually transmitted diseases-i
10/29/2009US20090269285 Diagnostic And Therapeutic Epitope, And Transgenic Plant
10/29/2009US20090268511 Bacteriorhodopsin Protein Variants and Methods of Use for Long Term Data Storage
10/29/2009CA2722558A1 Methods for preparing immunogenic compositions
10/29/2009CA2722329A1 Artificial protein scaffolds
10/29/2009CA2722278A1 Systems, methods and compositions for optical stimulation of target cells
10/29/2009CA2722238A1 Liver-specific nucleic acid regulatory elements and methods and use thereof
10/29/2009CA2722043A1 Nucleic acid comprising chimeric gene derived from hepatitis c virus
10/29/2009CA2721870A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
10/29/2009CA2721833A1 Prion epitopes and methods of use thereof
10/29/2009CA2721657A1 Vaccine compositions for the treatment of dengue fever and uses thereof
10/29/2009CA2721582A1 Recombinant deamidated gliadin antigen
10/29/2009CA2720465A1 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
10/29/2009CA2664405A1 Methods of altering plant phenotypes by suppressing function of cil1 protein or homolog thereof
10/28/2009EP2112234A2 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
10/28/2009EP2112231A2 MarA family helix-turn-helix domains and methods of use
10/28/2009EP2112229A2 Methods for identifying risk of breast cancer and treatments thereof
1 ... 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 ... 2916